HEADER VIRAL PROTEIN 03-AUG-21 7FJC TITLE CRYSTAL STRUCTURE OF SARS-COV-2 BETA RBD COMPLEXED WITH P36-5D2 FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: P36-5D2 HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: P36-5D2 LIGHT CHAIN; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: E; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 13 2; SOURCE 14 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 15 ORGANISM_TAXID: 2697049; SOURCE 16 GENE: S, 2; SOURCE 17 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS SARS-COV-2 VARIANT OF CONCERN, BETA, RBD, NEUTRALIZATION ANTIBODY, KEYWDS 2 VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.Q.ZHANG,X.Q.WANG,S.S.SHAN,J.LAN REVDAT 2 29-NOV-23 7FJC 1 REMARK REVDAT 1 10-AUG-22 7FJC 0 JRNL AUTH L.Q.ZHANG,X.Q.WANG,S.S.SHAN,J.LAN JRNL TITL CRYSTAL STRUCTURE OF SARS-COV-2 BETA RBD COMPLEXED WITH JRNL TITL 2 P36-5D2 FAB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 3 NUMBER OF REFLECTIONS : 16640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.160 REMARK 3 FREE R VALUE TEST SET COUNT : 859 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.4800 - 5.3800 0.97 2788 158 0.2001 0.2384 REMARK 3 2 5.3800 - 4.2700 0.98 2742 130 0.1751 0.2182 REMARK 3 3 4.2700 - 3.7300 0.99 2745 164 0.2024 0.2855 REMARK 3 4 3.7300 - 3.3900 0.97 2677 139 0.2268 0.3023 REMARK 3 5 3.3900 - 3.1500 0.98 2660 155 0.2927 0.3805 REMARK 3 6 3.1500 - 2.9600 0.80 2169 113 0.3215 0.3685 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 86.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -16.1651 4.8903 27.5828 REMARK 3 T TENSOR REMARK 3 T11: 0.6734 T22: 0.4116 REMARK 3 T33: 0.5067 T12: 0.0413 REMARK 3 T13: 0.0138 T23: -0.0329 REMARK 3 L TENSOR REMARK 3 L11: 2.2879 L22: 1.7788 REMARK 3 L33: 3.4133 L12: -1.0534 REMARK 3 L13: 2.3928 L23: -1.8080 REMARK 3 S TENSOR REMARK 3 S11: -0.0261 S12: 0.0220 S13: 0.1361 REMARK 3 S21: 0.0334 S22: -0.2043 S23: -0.2928 REMARK 3 S31: 0.0312 S32: 0.3610 S33: 0.2678 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7FJC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1300023314. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9798 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16679 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.960 REMARK 200 RESOLUTION RANGE LOW (A) : 43.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.07 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6M0J, 6RCS, 7K8R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM HEPES 7.5, 10% W/V REMARK 280 PEG6000, 5% V/V MPD, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 289.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 82.55500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.05650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 82.55500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.05650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, E, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN H 1 REMARK 465 LYS H 138 REMARK 465 SER H 139 REMARK 465 THR H 140 REMARK 465 SER H 141 REMARK 465 GLY H 142 REMARK 465 ALA E 475 REMARK 465 GLY E 476 REMARK 465 SER E 477 REMARK 465 THR E 478 REMARK 465 PRO E 479 REMARK 465 CYS E 480 REMARK 465 ASN E 481 REMARK 465 GLY E 482 REMARK 465 VAL E 483 REMARK 465 GLU E 484 REMARK 465 GLY E 485 REMARK 465 PHE E 486 REMARK 465 ASN E 487 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASN E 439 OG SER E 443 2.11 REMARK 500 OG SER H 212 OG1 THR H 214 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS L 140 CA - CB - SG ANGL. DEV. = 6.9 DEGREES REMARK 500 ARG E 466 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER H 88 -13.37 71.64 REMARK 500 SER H 122 56.70 -96.97 REMARK 500 SER L 30 -58.94 -20.30 REMARK 500 ALA L 51 -19.37 71.34 REMARK 500 SER L 52 -14.38 -145.73 REMARK 500 PRO L 95 130.05 -11.32 REMARK 500 PRO L 147 -179.13 -66.06 REMARK 500 SER L 168 146.66 -177.05 REMARK 500 SER L 208 -14.78 68.24 REMARK 500 SER L 209 136.77 -172.60 REMARK 500 ALA E 352 41.20 -103.31 REMARK 500 TRP E 353 157.79 -49.29 REMARK 500 ALA E 372 19.14 52.66 REMARK 500 PRO E 384 2.62 -59.69 REMARK 500 LEU E 387 -3.43 75.52 REMARK 500 ASP E 389 48.19 -84.48 REMARK 500 THR E 415 20.80 -141.67 REMARK 500 ASN E 422 -37.93 -130.31 REMARK 500 PHE E 464 -1.59 66.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE H 155 PRO H 156 137.62 REMARK 500 GLN L 6 SER L 7 -149.78 REMARK 500 ILE L 29 SER L 30 -128.97 REMARK 500 TYR L 94 PRO L 95 -83.63 REMARK 500 REMARK 500 REMARK: NULL DBREF 7FJC H 1 222 PDB 7FJC 7FJC 1 222 DBREF 7FJC L 1 220 PDB 7FJC 7FJC 1 220 DBREF 7FJC E 333 519 UNP P0DTC2 SPIKE_SARS2 333 519 SEQADV 7FJC ASN E 417 UNP P0DTC2 LYS 417 CONFLICT SEQADV 7FJC TYR E 501 UNP P0DTC2 ASN 501 CONFLICT SEQADV 7FJC LEU E 516 UNP P0DTC2 GLU 516 CONFLICT SEQRES 1 H 222 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 H 222 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 H 222 TYR THR PHE THR THR TYR ALA MET HIS TRP VAL ARG GLN SEQRES 4 H 222 ALA PRO GLY GLN ARG LEU GLU TRP MET GLY TRP ILE ASN SEQRES 5 H 222 ALA GLY ASN GLY ASN THR LYS TYR SER GLN LYS PHE GLN SEQRES 6 H 222 GLY ARG VAL THR ILE THR ARG ASP THR SER ALA SER THR SEQRES 7 H 222 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 H 222 ALA VAL TYR TYR CYS ALA GLY GLY GLY GLY ARG ARG LEU SEQRES 9 H 222 GLN PHE ASP TYR PHE ASP TYR TRP GLY GLN GLY THR LEU SEQRES 10 H 222 VAL THR VAL SER SER ALA SER THR LYS GLY PRO SER VAL SEQRES 11 H 222 PHE PRO LEU ALA PRO SER SER LYS SER THR SER GLY GLY SEQRES 12 H 222 THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO SEQRES 13 H 222 GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SEQRES 14 H 222 SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER SEQRES 15 H 222 GLY LEU TYR SER LEU SER SER VAL VAL THR VAL PRO SER SEQRES 16 H 222 SER SER LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN SEQRES 17 H 222 HIS LYS PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU SEQRES 18 H 222 PRO SEQRES 1 L 214 ASP ILE GLN MET THR GLN SER PRO SER THR LEU SER ALA SEQRES 2 L 214 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 L 214 GLN SER ILE SER SER TRP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 L 214 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ASP ALA SER SEQRES 5 L 214 SER LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 214 GLY SER GLY THR GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 L 214 GLN PRO ASP ASP PHE ALA THR TYR TYR CYS GLN GLN TYR SEQRES 8 L 214 ASN GLY TYR PRO TRP THR PHE GLY GLN GLY THR LYS VAL SEQRES 9 L 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 L 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 L 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 L 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 L 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 L 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 L 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 L 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 L 214 PHE ASN ARG GLY GLU CYS SEQRES 1 E 187 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 E 187 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 E 187 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 E 187 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 E 187 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 E 187 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 E 187 ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN TYR SEQRES 8 E 187 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 E 187 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 E 187 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 E 187 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 E 187 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 E 187 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR TYR SEQRES 14 E 187 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 E 187 PHE LEU LEU LEU HIS HET NAG A 1 14 HET FUC A 2 10 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 4 NAG C8 H15 N O6 FORMUL 4 FUC C6 H12 O5 HELIX 1 AA1 GLN H 62 GLN H 65 5 4 HELIX 2 AA2 THR H 74 ALA H 76 5 3 HELIX 3 AA3 SER H 196 LEU H 198 5 3 HELIX 4 AA4 GLN L 79 PHE L 83 5 5 HELIX 5 AA5 GLU L 129 SER L 133 5 5 HELIX 6 AA6 LYS L 189 HIS L 195 1 7 HELIX 7 AA7 PRO E 337 ASN E 343 1 7 HELIX 8 AA8 SER E 349 TRP E 353 5 5 HELIX 9 AA9 TYR E 365 ASN E 370 1 6 HELIX 10 AB1 ASP E 405 ILE E 410 5 6 HELIX 11 AB2 GLY E 416 ASN E 422 1 7 HELIX 12 AB3 SER E 438 SER E 443 1 6 SHEET 1 AA1 4 GLN H 3 GLN H 6 0 SHEET 2 AA1 4 SER H 17 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 AA1 4 THR H 78 SER H 84 -1 O MET H 81 N VAL H 20 SHEET 4 AA1 4 VAL H 68 ASP H 73 -1 N ASP H 73 O THR H 78 SHEET 1 AA2 6 ALA H 9 LYS H 12 0 SHEET 2 AA2 6 THR H 116 VAL H 120 1 O THR H 119 N LYS H 12 SHEET 3 AA2 6 ALA H 92 GLY H 99 -1 N TYR H 94 O THR H 116 SHEET 4 AA2 6 ALA H 33 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 5 AA2 6 LEU H 45 ASN H 52 -1 O GLU H 46 N ARG H 38 SHEET 6 AA2 6 THR H 58 TYR H 60 -1 O LYS H 59 N TRP H 50 SHEET 1 AA3 3 SER H 129 VAL H 130 0 SHEET 2 AA3 3 VAL H 151 TYR H 154 -1 O LYS H 152 N SER H 129 SHEET 3 AA3 3 TYR H 185 LEU H 187 -1 O TYR H 185 N TYR H 154 SHEET 1 AA4 3 THR H 144 GLY H 148 0 SHEET 2 AA4 3 SER H 189 PRO H 194 -1 O VAL H 193 N ALA H 145 SHEET 3 AA4 3 VAL H 172 THR H 174 -1 N HIS H 173 O VAL H 190 SHEET 1 AA5 3 THR H 160 TRP H 163 0 SHEET 2 AA5 3 TYR H 203 HIS H 209 -1 O ASN H 206 N SER H 162 SHEET 3 AA5 3 THR H 214 VAL H 220 -1 O VAL H 216 N VAL H 207 SHEET 1 AA6 4 MET L 4 GLN L 6 0 SHEET 2 AA6 4 VAL L 19 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 3 AA6 4 GLU L 70 ILE L 75 -1 O PHE L 71 N CYS L 23 SHEET 4 AA6 4 PHE L 62 SER L 65 -1 N SER L 63 O THR L 74 SHEET 1 AA7 6 THR L 10 ALA L 13 0 SHEET 2 AA7 6 THR L 102 ILE L 106 1 O GLU L 105 N LEU L 11 SHEET 3 AA7 6 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AA7 6 LEU L 33 GLN L 38 -1 N GLN L 38 O THR L 85 SHEET 5 AA7 6 LYS L 45 TYR L 49 -1 O ILE L 48 N TRP L 35 SHEET 6 AA7 6 SER L 53 LEU L 54 -1 O SER L 53 N TYR L 49 SHEET 1 AA8 4 THR L 10 ALA L 13 0 SHEET 2 AA8 4 THR L 102 ILE L 106 1 O GLU L 105 N LEU L 11 SHEET 3 AA8 4 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AA8 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 AA9 4 SER L 120 PHE L 124 0 SHEET 2 AA9 4 THR L 135 PHE L 145 -1 O LEU L 141 N PHE L 122 SHEET 3 AA9 4 TYR L 179 SER L 188 -1 O LEU L 185 N VAL L 138 SHEET 4 AA9 4 SER L 165 GLN L 166 -1 N GLN L 166 O THR L 184 SHEET 1 AB1 4 ALA L 159 GLN L 161 0 SHEET 2 AB1 4 ALA L 150 VAL L 156 -1 N VAL L 156 O ALA L 159 SHEET 3 AB1 4 VAL L 197 HIS L 204 -1 O ALA L 199 N LYS L 155 SHEET 4 AB1 4 VAL L 211 ASN L 216 -1 O VAL L 211 N VAL L 202 SHEET 1 AB2 5 ASN E 354 ILE E 358 0 SHEET 2 AB2 5 ASN E 394 ARG E 403 -1 O VAL E 395 N ILE E 358 SHEET 3 AB2 5 PRO E 507 LEU E 516 -1 O VAL E 512 N ASP E 398 SHEET 4 AB2 5 GLY E 431 ASN E 437 -1 N ILE E 434 O VAL E 511 SHEET 5 AB2 5 THR E 376 CYS E 379 -1 N LYS E 378 O VAL E 433 SHEET 1 AB3 2 LEU E 452 ARG E 454 0 SHEET 2 AB3 2 LEU E 492 SER E 494 -1 O GLN E 493 N TYR E 453 SSBOND 1 CYS H 22 CYS H 96 1555 1555 2.05 SSBOND 2 CYS H 149 CYS H 205 1555 1555 2.04 SSBOND 3 CYS L 23 CYS L 88 1555 1555 2.07 SSBOND 4 CYS L 140 CYS L 200 1555 1555 2.04 SSBOND 5 CYS E 336 CYS E 361 1555 1555 2.04 SSBOND 6 CYS E 379 CYS E 432 1555 1555 2.08 LINK ND2 ASN E 343 C1 NAG A 1 1555 1555 1.48 LINK O6 NAG A 1 C1 FUC A 2 1555 1555 1.46 CISPEP 1 TYR L 146 PRO L 147 0 -5.12 CRYST1 165.110 42.113 122.089 90.00 102.79 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006057 0.000000 0.001375 0.00000 SCALE2 0.000000 0.023746 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008399 0.00000